Atlas Trials

The Effect of an Oral Supplement,TK3 (Tryptophan and Thiamine) on the Quality of Life and Chemotherapy Tolerance in Cancer Patients With Advanced Disease.

Clinical trial NCT03341286 · UNKNOWN

Trial details

NCT number
NCT03341286
Sponsor
Faculdade de Medicina do ABC
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
CancerQuality of LifeChemotherapy EffectTryptophanThiamine
Start date
2017-11-01
Primary completion
2019-01-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.